PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Baylor University Medical Center, Dallas, Texas, USA.\', \'Baylor Scott & White Research Institute, Dallas, Texas, USA.\', \'Texas A&M Health Science Center, Dallas, Texas, USA.\', \'AlloVir, Cambridge, Massachusetts, USA.\', \'TCU and University of North Texas Health Science Center, Fort Worth, Texas, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/ajt.16927
?:hasPublicationType
?:journal
  • American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
is ?:pmid of
?:pmid
?:pmid
  • 34910857
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • ALVR109, an off-the-shelf partially HLA matched SARS-CoV-2-specific T cell therapy, to treat refractory severe COVID-19 pneumonia in a heart transplant patient: Case report.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34910857>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34910857>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all